Roland Brosch obtained his PhD at the University of Salzburg in Austria and after some years of postdoctoral training at the University of Wisconsin in Madison and the Institut Pasteur in Paris, he integrated into the scientific staff of the Institut Pasteur in 2000. He is now Professor and Head of the Integrated Mycobacterial Pathogenomics Unit at the Institut Pasteur. He gained broad experience in mycobacterial research in the tuberculosis (TB) research field, where he had important impact on groundbreaking genome projects of Mycobacterium tuberculosis, the etiological agent of TB, the BCG vaccine, and the ancestral gene pool of TB-causing mycobacteria (Mycobacterium canettii). He was also involved in pioneering work on the evolution of the M. tuberculosis complex and the discovery and functional characterization of the ESX / type VII secretion system of M. tuberculosis. He continues to be very interested in these topics, which remain key issues for the identification of new virulence mechanisms of M. tuberculosis, for elucidating the extraordinary evolutionary success of M. tuberculosis, and for gaining new insights and perspectives into host-pathogen interaction, new vaccine concepts and therapeutic interventions.
Click to view graph
Connections
Click to view timeline
Timeline
Transversal Projects
Projects
Publications
Download-
2024Genomic and phenotypic characterization of Mycobacterium tuberculosis’ closest-related non-tuberculous mycobacteria., Microbiol Spectr 2024 May; (): e0412623.
-
2024A host-directed oxadiazole compound potentiates antituberculosis treatment via zinc poisoning in human macrophages and in a mouse model of infection., PLoS Biol 2024 Apr; 22(4): e3002259.
-
2024Evolution and emergence of Mycobacterium tuberculosis., FEMS Microbiol Rev 2024 Mar; 48(2): .
-
2023Natural mutations in the sensor kinase of the PhoPR two-component regulatory system modulate virulence of ancestor-like tuberculosis bacilli., PLoS Pathog 2023 Jul; 19(7): e1011437.
-
2022Author Correction: A comprehensive update to the Mycobacterium tuberculosis H37Rv reference genome., Nat Commun 2022 Dec; 13(1): 7538.
-
2022A comprehensive update to the Mycobacterium tuberculosis H37Rv reference genome., Nat Commun 2022 Nov; 13(1): 7068.
-
2022A lentiviral vector expressing a dendritic cell-targeting multimer induces mucosal anti-mycobacterial CD4+ T-cell immunity., Mucosal Immunol 2022 Sep; (): .
-
2022A lentiviral vector encoding fusion of light invariant chain and mycobacterial antigens induces protective CD4+ T cell immunity., Cell Rep 2022 Jul; 40(4): 111142.
-
2022The C terminus of the mycobacterium ESX-1 secretion system substrate ESAT-6 is required for phagosomal membrane damage and virulence., Proc Natl Acad Sci U S A 2022 03; 119(11): e2122161119.
-
2022The Mycobacterium tuberculosis PhoPR virulence system regulates expression of the universal second messenger c-di-AMP and impacts vaccine safety and efficacy., Mol Ther Nucleic Acids 2022 Mar; 27(): 1235-1248.
-
+View full list of publications